Freestone Grove Partners’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Freestone Grove Partners's QGEN Position: Q2 2026 in Review
Freestone Grove Partners increased its Qiagen (QGEN) stake by 98% in Q2 2026, buying an estimated $24.1M and bringing the position to 1,311,722 shares worth $51.3M. The position accounts for 0.33% of the portfolio, ranked #80.
Freestone Grove Partners first reported a position in QGEN in Q4 2024 and has held it in 4 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Freestone Grove Partners held 1,311,722 shares of Qiagen worth $51.3M as of Q2 2026.
- Freestone Grove Partners bought 649,865 Qiagen shares in Q2 2026, an estimated $24.1M.
- Qiagen made up 0.33% of Freestone Grove Partners's portfolio in Q2 2026, its #80 holding.
- Freestone Grove Partners first reported a position in Qiagen in Q4 2024 and has held it in 4 quarters since.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.